22nd century tobacco expands markets and brand agreements for VLN products 22nd Century Reports $4.1M in
22nd Century Reports $4.1M in Revenue as it Focuses on Future Tobacco Reporter 22nd Century Group Partners with Tobacco Brands to Promote VLN Reduced Nicotine Cigarettes in Compliance with FDA Standards Quiver Quantitative 22nd Century Group Tobacco Reporter 22nd Century Group, Inc. Montrose Capital Partners FDA Authorizes Marketing of 22nd Century Group's VLN as a Modified Risk Tobacco Product Be Korea savvy
Pay in 4 interest-free payments of $6.59 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4




